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Abstract 
For the treatment and monitoring of Parkinson disease (PD) to be scientific, a key requirement is that 
measurements of disease stages and severity are quantitative, reliable and repeatable. The last 50 
years in PD research have been dominated by qualitative, subjective ratings obtained by human 
interpretation of the presentation of disease features at clinical visits. More recently, “wearable”, 
sensor-based, quantitative, objective, and easy-to-use systems for quantifying PD signs for large 
numbers of participants over extended durations have been developed. This technology has the 
potential to significantly improve both clinical diagnosis and management in PD and the conduct of 
clinical studies. However, the large-scale, high-dimensional character of the data captured by these 
wearable sensors requires sophisticated signal processing and machine learning algorithms to 
transform it into scientifically and clinically meaningful information. Such algorithms that “learn” 
from data have shown remarkable success at making accurate predictions for complex problems 
where human skill has been required to-date, but they are challenging to evaluate and apply without 
a basic understanding of the underlying logic upon which they are based. This article contains a non-
technical, tutorial review of relevant machine learning algorithms, also describing their limitations 
and how these can be overcome. It discusses implications of this technology and a practical roadmap 
for realizing the full potential of this technology in PD research and practice. 
Introduction 
Medical practice aspires to diagnose patients at the earliest of clinical signs; to monitor disease 
progression and rapidly find optimal treatment regimens. Clinical scientists and drug developers seek 
to enroll large numbers of participants into trials with minimal cost and effort, to maximize scientific 
validity of studies. Patients wish to increase their quality of life while reducing physical clinic visits, 
and patient care seeks to minimize reliance on the clinic and transition into patient’s homes. In this 
article we describe a combination of technologies – wearable devices and machine learning – which 
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may be key to these aspirations. These technologies promise to enable this vision by providing 
objective, high-frequency, sensitive and continuous data on the signs of PD. 
Machine learning systems have become a pervasive part of modern life. As examples, mail delivery 
corporations use machine vision algorithms to automatically transcribe hand written addresses on 
envelopes to route them to their intended destination, and vehicle license plate reading algorithms 
automatically track vehicles around road networks based upon images captured using roadside 
digital cameras.1 In both applications, without machine learning it would require human skill and 
constant attention to carry out the transcription, but machine learning software performs this task to 
almost human levels of accuracy, but with far superior speed and reliability. 
Meanwhile, consumer devices such as cell phones, smartphones and more recently smartwatches 
are worn and used by nearly a third of the world’s population on a daily basis.2 These devices are 
fully-featured, Internet and telephone network connected wearable computers (“wearables”) 
incorporating numerous digital sensors measuring physical quantities of the wearer and their 
environment. They put the vast combined utility of cell phones, laptops and desktop computers in 
the hands of the wearer, 24 hours a day, in almost any environment. 
These twin technologies – wearables and machine learning – have developmental histories driven by 
rapid advances in hardware miniaturization, computing power, mass data storage, Internet-enabled 
information accessibility, and conceptual advances in computer science, software engineering and 
mathematics. These advances have reached the point at which wearable devices with machine 
learning, might allow cheap, reliable, validated disease process-relevant measurements, which would 
normally only be collected at infrequent, physical clinic or research center visits, if at all. 
Wearable sensor data is complex because it is high frequency (rates of hundreds to thousands of 
observations per second) and often high-dimensional (many different sensors capturing multiple 
forms of data simultaneously) and so it is high volume. Machine learning methods are widely 
applicable to many kinds of data, but wearable sensor data is particularly difficult to visualize, 
understand and manage without specialized algorithms such as those used to process and analyze 
digital sensor data collected in other industrial applications such as mail sorting or speech 
recognition. 
Since these technologies have only really matured in the last 10 years, they are unlikely to have 
formed part of the traditional training of clinicians and clinical researchers. The objective of this 
article is to present what machine learning is, the terminology used and its relationship to that used 
in traditional biomedical statistics (Table 2) and how it may be applied to wearable sensor data in 
clinical PD measurement, provide a short tutorial on the most relevant machine learning methods, 
and describe the major pitfalls and limitations of machine learning-based approaches to sensor data 
analysis, and how these limitations can be mitigated. 
Defining wearables and statistical machine learning 
Here we define a wearable device/wearable as an electronic device which is small, easily and 
comfortably worn, for extended periods of time, on some part(s) of the body. The device contains 
digital sensors measuring particular physical parameters such as acceleration, light flux, sound 
pressure, skin temperature or blood volume. We include ‘quasi-wearable’ devices such as 
smartphones within this definition. Wearables can be consumer or medical. Consumer refers to 
devices with no specific clinical function but which can be reprogrammed to perform clinical 
measurement (clinimetric) functions. Medical devices are designed and marketed for specific clinical 
purposes. 
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Machine learning is usually defined as the application of mathematical algorithms that can find 
arbitrary patterns or structure in data, and make predictions for new input data.3 Unlike traditional 
programming where complex algorithms are designed and programmed to produce exactly specified 
outputs, machine learning attempts to “self-program” from data alone, mimicking the human ability 
to synthesize rules from data. 
The distinct character of wearable sensor data versus traditional clinical neurology data 
PD wearable data is radically different from traditional clinical data, which is a ‘static’, small-scale, 
subjective snapshot of PD status. Traditional data is often comprised of demographic attributes (for 
example age and gender), and disease data (such as date of first symptom onset, diagnostic category, 
and ordinal-scale UPDRS questions).4 It takes substantial time and effort to collect such data, so even 
the most detailed studies collect at most 200 or so data items at each patient visit, with months 
between visits. 
By contrast, wearable data comprises ‘continuous’ high-frequency digital sensor readings, potentially 
tens of thousands per second, reporting quantities such as acceleration, rate of rotation, blood 
volume, acoustic pressure, skin temperature, GPS coordinates, magnetic field strength and ambient 
light flux. 
Of course, traditional data has merits: for example, a clinical rater, although inherently subjective, 
synthesizes vast amounts of sensory information about the subject, and can actively seek out 
confirmatory data from disparate sources in order to reach a holistic diagnosis or disease severity 
assessment. 
Example large-scale wearables studies in PD research: detecting medication 
responsiveness 
Here we pick out two large-scale consumer wearable studies providing an indication of what might 
be achievable in future. 
The “Smartphone-PD” global observational study recruits healthy and PD participants using software 
downloaded to participant’s own Android smartphones.5 As of 2015, 457 individuals were recruited 
and over 46,000 hours of raw sensor data captured for 6 months’ duration from each participant, 
including GPS location, accelerometry, gyroscope, magnetometer, proximity and ambient light flux. 
Sensor data from short (less than 5 minute) controlled, systematic tests of gait, voice, touchscreen 
tapping, postural and rest tremor conducted using the smartphone allowed a machine learning 
algorithm to discriminate drug-responsive from non-responsive participants,6 and to quantify the 
level of responsiveness to treatments against l-dopa equivalent dosage. Similar results were found in 
the US-wide “mPower” iPhone-based study of PD.7 Here, touchscreen tapping sensor data from 57 
PD participants was analyzed using various machine learning algorithms. Individualized medication 
responsiveness was also quantifiable using this tapping data. 
This evidence for the clinical utility of this approach is promising: drug titration and timing is a 
delicate problem in PD disease management which might be substantially improved by real-time, 
objective and validated assessment of potential new treatments for PD. Many other smaller-scale 
studies have used machine learning for wearable device data in PD (Table 1). 
Machine learning: a brief tutorial 
Statistical machine learning methods subsume most traditional statistical methods used in 
biomedicine, for example: parametric and non-parametric null hypothesis testing, linear and logistic 
regression, discriminant analysis, principal components, factor analysis and cluster analysis. Typically, 
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machine learning extends these methods to cope with high-dimensionality and nonlinearity which is 
of particular importance in wearable sensor data. It overlaps with artificial intelligence but the 
problems it seeks to solve are usually recognizable to traditional biomedical statistics (Table 2). 
Statistical machine learning is one of the fastest-growing scientific disciplines; we describe the 
primary conceptual ‘branches’ and their importance in PD wearable data analysis. 
Signal processing: data conditioning and feature extraction 
A prerequisite of most machine learning approaches to sensor data analysis is the preparation of the 
digital data by identifying useful regions to process (segmentation). This signal processing is usually 
essential because in practice, sensor data is not always meaningful, for example, if the wearable is 
not actually being worn.8 Once reliably segmented, these data can then be summarized into a small 
set of features, which are then input to the machine learning algorithm.1 Feature extraction makes 
the machine learning problem tractable, because it substantially reduces the number of data 
dimensions. 
Supervised machine learning 
Supervised learning trains an algorithm to mimic some input-output relationship (Figure 1A). Such 
methods require labeled data: each training input must be associated with an output value. We have 
examples of input paired with output data, and the algorithm finds a rule which maps the input data 
onto the output. The pattern to be learned is this rule, which can be used to make predictions when 
given new inputs. Depending upon the kind of output data – whether it takes a continuous range of 
values or a finite discrete set – the mathematical mapping is known as regression or classification, 
respectively. 
Regression: As an example, consider output data where the labels represent clinically-scored severity 
of a PD sign (say, on the scale 0-100), and some (simplified) features related to that sign from a 
wearable device. In this situation, regression can form an automatic way of predicting the clinical 
score using the device. This approach has been used to predict UPDRS ratings from digital voice 
recordings, accelerometers, and touch screens.9 For example, Stamatakis et al.10 demonstrate logistic 
regression to predict UPDRS from features of performance on a finger tapping test recorded by 
accelerometer. 
In classical statistical techniques such as linear regression and linear discriminant analysis this 
mapping rule is linear: that is, the classification decision boundary or regression curve is a hyperplane 
(e.g. line or a plane and equivalent geometric object in higher dimensions). By contrast, many 
supervised machine learning algorithms are in principal capable of discovering any nonlinear 
relationship.1 This makes them particularly suited to finding high-dimensional, complex rules. These 
kinds of relationships might be impossible to intuit, but they are abundant when dealing with 
biomedical data, so one is often forced to use machine learning algorithms. 
Classification: This method finds significant applications separating (discriminating) between two or 
more discrete output values.1 An archetypal application example of machine learning classification is 
diagnosis: discriminating between healthy and PD cases. By comparing the expert diagnosis (the 
labels) against the predicted diagnosis from the classifier, all the familiar metrics of diagnostic 
performance such as sensitivity, specificity, positive and negative predictive value, ROC and AUC 
values (for classifiers with probabilistic outputs) can be computed. However, machine learning 
classifiers can produce classifications from high-dimensional input data where they find a general 
decision boundary in the input space which separates the data into the separate classes (e.g. healthy 
versus PD). Example classifiers include the support vector machine (SVM; Figure 2A) which can in 
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principle find a boundary of any complexity; Patel et al.11 use SVMs to identify patients with PD from 
accelerometer data. 
Other examples of classifiers include the artificial neural network (Figure 2B) which mimics the gross 
hierarchical connectivity of biological neural circuitry1; Jane et al.12 used neural networks to detect 
PD gait disturbances from wearable accelerometers. More recent incarnations such as the 
convolutional neural network have shown state-of-the-art prediction accuracy in applications such as 
image and speech identification13, although their robustness to confounding factors is somewhat in 
doubt14. 
Decision trees are another widely-used classification algorithm which finds a decomposition of the 
input space into high-dimensional, hierarchically nested rectangular regions, assigning an optimal 
class label per region, the decomposition represented as a tree-like diagram (hence the name). The 
technique is substantially enhanced in accuracy by randomization and resampling – using many 
different possible decompositions – leading to random forest classification. Arora et al.9 used random 
forests in discriminating patients with PD from controls from a broad variety of smartphone sensor 
data. 
Unsupervised machine learning 
Supervised methods require labeled data and this is very often a difficult situation to arrange, 
particularly so for large-scale wearable data. Unsupervised machine learning methods do not require 
labeled data as the method attempts to find the parameters of specific structure in the input data 
(Figure 1B).1, 3 
(Unsupervised) clustering partitions the data into separate groups (clusters), each with 
representative characteristics. When making predictions, clustering techniques, much like classifiers, 
map an unknown input onto a discrete output value which is the identifier for the closest cluster to 
that input data. A classic example is K-means which attempts to group the data so as to minimize the 
total distance between the center of each cluster and each input data point. The learned parameters 
are the cluster centers, and the process creates clusters which are approximately spherical in the 
input space. K-means is fairly well established in PD studies which seek to identify sub-types of PD, 
such as those who are tremor-dominant versus those with rapid motor function decline and 
cognitive impairment.15 
In clustering, each data point is assigned to only one cluster: clusters do not overlap. However, in 
many situations this is an unrealistic simplification; it is more accurate to presume that the clusters 
overlap. In techniques such as mixture modeling the clustering is assumed to be uncertain, so that 
each data point is given a probability of belonging to every cluster.3 
Dimensionality reduction 
Most PD wearable data comprises an enormous number of separate measurements so it is said to 
have a large dimensionality. However, it may be the case that the intrinsic dimensionality of the data 
is much smaller. Consider 3D data with (X,Y,Z) coordinates for each data point, but where the data 
actually all lies on a 2D plane embedded in this 3D space. Any point on that flat ‘object’ can be 
located by specifying just two coordinates (X, Y). Dimensionality reduction attempts to find such 
lower-dimensional data structures embedded in very high-dimensional input spaces.1 Making 
predictions involves finding the corresponding coordinates of the higher-dimensional input data 
point on the lower-dimensional object. 
Assuming linear relationships in the data, the classical principal components analysis (PCA) finds 
hyperplanes, that is, lines, planes and their higher-dimensional analogs. Linearity is also assumed in 
Machine learning for PD wearables 
Page 6 of 19 
independent components analysis (ICA), which makes less restrictive mathematical assumptions 
about the data.1 By contrast, a large variety of manifold learning methods can find arbitrary, 
nonlinear low-dimensional geometric objects.16 In PD research PCA and related techniques have 
been used to find a few intrinsic dimensions of PD signs within high-dimensional UPDRS data.17, 18 
Advanced machine learning methods 
Advances in machine learning research have led to a wide variety of other algorithms, we describe a 
few important ones here. For partially labeled data where only some of the output training data is 
available, semi-supervised techniques such manifold regularization can provide direct constraints on 
the structure of the data which helps to locate the classification decision boundary in the input space 
(Figure 1C).19 Most supervised algorithms can be applied to partially labeled through iterative self-
training by substituting for the unknown outputs with predictions from the method trained on the 
labeled data. Non-parametric Bayesian methods such as Gaussian processes allow for finding not 
only the optimal parameters from the training data, but also the appropriate number of parameters. 
Thus, non-parametric Bayesian methods can adapt to the complexity of the data as more data is 
encountered.20 For example, Dirichlet process mixture models in PD subtyping discover both the 
number of subtypes and the representative clinical characteristics of each subtype.21 
Pitfalls and remedies of machine learning 
Wearable PD data analysis will usually require statistical machine learning algorithms of varying 
sophistication to make clinical sense of this data. There are many traps to be avoided if wearables are 
to find practical use in clinical applications. Here we discuss several of these issues and how they 
might be addressed. 
Overfitting and underfitting: finding the right model 
Science is not just about collecting data, it is concerned with formalizing general hypotheses about all 
the relevant data, which can make predictions to be tested. Prediction accuracy is crucial to the 
practical value of the hypothesis. Thus one goal of science is to come up with models (hypotheses 
based on assumptions) which are at exactly the right level of simplicity/complexity to predict the 
relevant observed and unobserved data. As a familiar example, classical null hypothesis testing can 
be considered as a model selection problem in which we select between a simple null and a more 
complex alternative hypothesis. This principle of tuning the complexity of a model, also known as 
Occam’s razor, has a counterpart in algorithms for wearable data analysis embodied in the 
complementary concepts of overfitting and underfitting.1 
An overfitted model is more complex than can be justified by the data. An overfitted model might 
have too many free parameters and thus risks confusing random noise or other confounds in the 
training data for genuine disease-related structure. This is a pervasive problem in statistical machine 
learning because the complexity of the model can often be set as high as required to get arbitrarily 
high prediction accuracy. An example: with K-means it is possible to get the prediction error as low as 
desired by simply increasing the number of clusters, K, and if each data point has its own cluster, zero 
prediction error can be obtained. Of course, this would not be a meaningful clustering, but it 
illustrates what can go wrong with careless use of machine learning algorithms. The opposite 
situation, where the model is too simple, is known as underfitting: such a model will be insensitive to 
the actual disease-related structure in the data, producing predictions with poor accuracy. 
The (inevitably imperfect) remedy is appropriate complexity control, a critically important and 
weighty topic. The more robust machine learning algorithms have some kind of complexity control 
parameter (and Bayesian algorithms naturally incorporate complexity control through the “spread” 
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of the prior distribution over the model’s parameters) but many can be adapted to use sampling-
based approaches which we discuss below. However, there are inherent strengths and weaknesses 
to all forms of complexity control and no technique is guaranteed to find the ideal solution under all 
circumstances.1, 22 
Hold-out testing is a popular sampling approach to complexity control. The data is split into testing 
and training subsets, and the algorithm parameters are found from the training subset. The 
prediction accuracy is computed on the test subset. Thus, no information from the training subset is 
used in testing the algorithm. Since the test subset will always be a different random subset of the 
overall population data to the training subset, the machine learning technique is appropriately 
penalized for making overly accurate predictions on the training data. The rationale is that an 
algorithm which has perfect predictions for the training data has almost zero probability of making 
good predictions on the test data. In cross-validation, hold-out testing is repeated by randomized 
train/test splitting, and this leads to an estimate of the variability of the prediction error. This 
variability establishes a statistically meaningful confidence interval for the prediction error when 
predictions are made on the population data (which is unavailable in principle). 
The major weakness of cross-validation is that it requires every measurement in the data (grouping 
all dimensions together into one measurement) to be (1) statistically independent of all the rest, and 
yet (2) share the same statistical distribution as all the rest of the measurements, and (3) this 
distribution must match the population distribution.22 These three strict conditions make the 
problem of distributional mismatch acute: for example, if there is any internal heterogeneity in the 
data, then each training subset is unlikely to contain all the information required to learn the overall 
structure in the data. As a result, the predictions on the test set are unlikely to be accurate and hold-
out testing will give misleadingly low prediction accuracy. Unfortunately, identifying departures from 
these strict assumptions is, in the final analysis, as difficult as having a complete statistical model for 
the data, and this is, of course, exactly what we do not know and are trying to find! 
Another serious weakness with hold-out approaches is that of data leakage, where some unintended 
effect causes the training subset to inadvertently contain information about the test subset, which 
can dramatically undermine the independence between training and test subsets required to make 
this a valid procedure.23 It can be extremely hard to identify sources of data leakage because data 
can be confounded by all manner of unknown effects. This difficulty is compounded by the fact that 
there are often unintended interactions between the machine learning algorithm and the kind of 
leakage: some algorithms are less sensitive to leakage than others. 
Another test of prediction performance is replication, sometimes called true hold-out testing, which 
is analogous to prospective testing. Here, a completely different data set (ideally collected in another 
lab or in a different sample of the population) is used to test the prediction performance of the 
machine learning technique trained on the original data set. Replication helps to avoid problems such 
as data leakage, but it can sharpen the deleterious influence of distributional mismatch, because it is 
extremely hard to guarantee a perfect match in experimental conditions across different 
experimental settings. 
For sampling methods, replication testing is generally held to be the most faithful representation of 
how the machine learning method would perform for the population in general, followed by hold-out 
testing such as cross-validation. There are many different forms of cross-validation including: leaving 
out one sample or subject from the training set, or 90%-10% train/test splitting, and they all have 
different statistical properties which can entail differing estimates of the prediction error and 
confidence in these estimates. 
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The above suggests that data and algorithms go hand-in-hand: it is not possible to rely on wearable 
data alone – we need to supply some assumptions in order to make the data collection effort 
scientific. But this is why the choice of machine learning algorithm, and the underlying assumptions 
that each entails, is critical for the success of any machine learning approach to wearable data 
analysis; in other words, data alone do not suffice. Similarly, since there are inherent assumptions to 
any complexity control method which may not hold entirely true for the data it is necessary to 
compare the results obtained using several methods in order to gain a more comprehensive 
understanding of the performance of any machine learning algorithm. 
Data quality issues 
As discussed above, wearable data vastly exceeds the amount of data collected in classical clinical 
neurology applications, and there are many advantages to this. But, it is generally true that “big 
data” is not automatically better than small. This section examines some of the reasons why. 
One of the most pertinent issues is the perennial problem of sampling/selection bias, which is an 
unavoidable issue in just about every statistical study.24 The obvious population biases are uneven 
technology adoption in particular sub-populations, for example, the more vulnerable older PD 
patients are unlikely to have familiarity with contemporary technologies and so tend to select 
themselves out of wearable studies. Since they are likely to have advanced PD, wearable studies will 
have to be carefully planned and executed to avoid omitting the more severe PD cases. Similarly, 
there are behavioral sampling biases: imagine a wearable being charged and not worn during the 
“wearing off” period for a particular PD participant, that period is thereby omitted for that 
participant. These are obvious sampling biases, but there could be much more subtle biases that only 
come to light during replication attempts. These issues can be mitigated by the careful use of well-
known population sampling designs. 
One of the main advantages wearables is the possibility of continuous monitoring which can be 
scaled up to study sizes of thousands of individuals or larger, and to conduct studies in the “home 
setting” rather than the “lab”. The freedom to collect more realistic, unconstrained ambulatory data 
across large sections of the population is valuable but we lose a substantial amount of experimental 
control over the data collection. Studies conducted this way are fundamentally different to most 
classical clinical studies, in that participant behavior is largely unconstrained. So, we have little 
information from moment to moment about what participants are doing, with far greater 
opportunity for confounding effects to undermine any subsequent analysis. Analyzing behavioral 
data from wearables in PD is a nascent science, and there is still much that is unknown about how to 
establish vital contextual information from sensor data which allows us to take into account the 
effects of confounders. To mitigate this issue, it is suggested that multiple sources of sensor data 
should be collected so that context can be more easily established. 
Another major problem with data collection is potential lack of accuracy of labels. For example, 
where participants are prompted to state when they have taken their medications using a 
smartphone app, they may fail to report, or they may enter incorrect times and dosages. Of course, 
this problem is not unique to wearable studies, but the problem may be more acute than traditional 
studies because identifying a few bad labels among a huge number may be very difficult indeed. 
Machine learning algorithms which are explicitly designed to handle errors in labels have more 
recently been developed and may be useful in this situation. 
Data drift and non-stationarity 
The vast majority of machine learning algorithms make the implicit assumption that the distribution 
of the training data is static and unchanging over time. But, one of the unavoidable facts of human 
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behavior is that it is adaptable to the circumstances, flexible and changeable. When machine learning 
algorithms are trained on a particular data set, they are trained to discover structure which is specific 
to that data as if it is a sample from the population distribution. But in practice, it is rare for the 
population distribution to remain static, and it is very likely to drift over time in response to changing 
environmental or personal conditions of the wearer. Therefore, by the time the machine learning 
system is deployed the distribution of the observed data may no longer match that of the training 
data, causing the machine learning predictions to be invalid. 
There are several responses to this: simpler machine learning algorithms are less likely than more 
complex algorithms to be ‘brittle’ in the face of changing distributions, so that simpler methods can 
be preferred when data drift is expected.25 The problem with this approach is that simpler methods 
often produce less accurate predictions, because they are underfitted. An alternative is to re-train 
the algorithm on the data as it is accumulated in deployment, but this may require new labeled data 
which is difficult to obtain, and/or increased computational and implementation complexity which 
may rule out immediate user feedback applications. 
Lack of model interpretability 
Machine learning algorithms have unprecedented predictive power. They can make high-accuracy 
predictions and discover structure and relationships in data which would be well beyond the reach of 
any unaided human analyst to intuit. However, these techniques do not generally supply explanatory 
power. In other words, they are “black boxes” which ingest data to produce predictive outputs.26 
There is a major disadvantage to such opacity: if the algorithm goes wrong, it is difficult to find out 
why. Also, the only guaranteed way to probe the full behavior of these black boxes is to explore all 
possible combinations of the inputs, which, for high-dimensional wearable data, is intractable. In 
other words, a method such as a convolutional neural network is a powerful prediction machine, but 
is of severely limited utility for facilitating understanding of the structure in the data. 
This is a serious shortcoming because one of the main principles of science is explain structure in 
data, which can link up to existing knowledge and therefore corroborate, confirm, revise and extend 
our knowledge about reality. We are also missing a vital check on the validity of machine learning 
predictions which will have life-changing implications for patients if used to make clinical treatment 
decisions. Mitigating this problem requires careful attention to establishing the logical connections 
between the physical properties measured by the sensors, any features extracted and their 
relationship to the underlying physiology, and the mathematical structure of the machine learning 
algorithm used to make predictions. 
Technical implementation complexity 
One of the guiding principles of engineering is modularity: building a system out of parts which can 
be tested independently. Modularity allows us to isolate effects to particular components of the 
system and thus prevent failure in one part from causing catastrophic, system-wide failure. Most 
machine learning algorithms are, unfortunately, not modular at all. Small changes in one parameter 
can have substantial and largely unpredictable effects on all the rest of the model. All the input data 
must be in exactly the same form as it was when used to train the model.27 
These kind of strong dependencies and general ‘brittleness’ to even slight changes mean that the 
engineering complexity, particularly in system maintenance, is very high, and premature system 
design choices can have large knock-on consequences which cannot be addressed without 
considerable engineering effort. What this means in practice is that for wearable data, the route 
from data capture to algorithm development and into clinical deployment is far from easy, and it is 
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not clear at this stage whether the promising early results obtained in academic studies will actually 
translate to deployment. 
Of course, this is something that occurs with any nascent technology, but with machine learning, the 
gap between academic studies on the intellectual frontier and final technical implementation is 
wide.27 This is systemic to the academic enterprise because it is generally uninterested in the 
technical implementation details. Perhaps a useful analog is that machine learning algorithm 
research and development is like basic research, and technical implementation issues are like 
translational research, and as it stands at the moment, there is a disproportionate amount of effort 
and funding being put into the basic science, and little, if any, research into the translational aspects. 
Options to address this issue include careful design and testing of each component algorithm in the 
machine learning system to ensure that each component is robust and can function effectively when 
not part of the overall system. 
Technological difficulties arising 
As this field is nascent there is still much to understand about how to maximize the effectiveness of 
wearable data. For example, the raw digital data from a single sensor can, by itself, be misleading – in 
the Fox Insight study28, patients report that mowing the lawn or exercising can mimic a tremor, and 
derived smartphone assessments of gait parameters from this raw sensor data have also been 
inaccurate for participants living in a cluttered environment. 
So, while continuous wearable data is objective, it needs effective statistical signal processing for 
data quality control and high-accuracy prediction algorithms to be scientifically valuable. The 
transformation of raw data into a form that accurately reflects PD disease severity and progression 
requires continued research, even as large-scale studies such as Fox Insight28, Smartphone-PD5 and 
mPower7 continue to amass data. 
Conclusions and Future Directions 
From where we stand now with this technology, how will we get to a state where it fulfills its full 
potential in PD? We can identify several key steps: clinimetric algorithm validation, open platform 
standardization and dissemination, and data sharing.28 
Clinimetric validation is required for regulatory approval, much like the measurement of e.g. blood 
glycosylated hemoglobin or blood pressure. Over and above demonstrating ease of repetitive use, 
approval requires that (a) it provides an accurate parameter of a clinically relevant feature of the 
disease, (b) there is confirmed evidence that this parameter has an ecologically relevant response 
within some specific clinical application, and (c) a target numerical range exists where the parameter 
measures adequate treatment response. The specific clinimetric validation approach taken needs 
some care: although it is possible to use machine learning algorithms to map wearable sensor data 
onto existing clinical scales such as UPDRS9, this is a poor approach because wearable sensors can be 
far more sensitive and precise than subjective ratings. This suggests that we should look to other 
reliability measures such as test-retest, parallel forms or internal consistency testing.29 
Platform standardization requires that the software and algorithms are made publicly available for 
general and widespread use, because any technology lives or dies by the scale of its adoption and 
dissemination in the wider community. Since PD measurement is a niche technology application, it is 
unlikely to be profitably funded over the long term through private investment. However open 
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source communities can be committed to maintaining and improving on public interest projects such 
as this, substituting the need for investment with community-sourced ‘intellectual capital’. 
Finally, science demands continual replication and confirmation on new data, for which data sharing 
is key. At the same time as learning more about PD, by sharing data we can further refine algorithms 
and provide increasingly extensive and rigorous clinimetric validation evidence. This will require 
careful planning at the initial stages of clinical trial design using this technology, since participants 
need to be consented to share the data widely. There are many other considerations that arise from 




Figure 1: A graphical depiction of how machine learning algorithms can process input data from 
wearables in PD. In each panel the horizontal and vertical dimensions on the page represent values 
of “features” (see main text) of the wearable sensor data. For example, in a two-dimensional space 
as depicted here, each point is associated with two features, one for the horizontal and one for the 
vertical dimension. (A) Supervised methods use labeled training data (left, labels correspond to red 
and blue coloring) to make predictions about new data. Here, a supervised classifier learned on the 
training data is used to categorize new data in either the blue or red class (right). The learned class 
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decision boundary is depicted by the dashed line. (B) In PD wearable applications, labeled training 
data can be difficult to acquire but unlabeled training data is often available in large quantities. 
Unsupervised learning methods can use this unlabeled data (left) to learn the parameters of the 
relationship between data points. Here, a clustering algorithm identifies subgroups of the data (right, 
dashed ovals). This grouping implicitly separates the entire space of the data into two non-
overlapping regions assigned to each class, which can then be used to classify new input data, as with 
supervised classification. (C) Semi-supervised learning is a “blend” of supervised and unsupervised 
learning methods, using both labeled and unlabeled training data (left) to strengthen its class 
predictions (right). This allows full exploitation of datasets with both labeled and unlabeled data, a 




Figure 2: Common supervised learning algorithms. (A) Support vector machines (SVM) separate input 
data into classes using decision boundaries which are high-dimensional analogs of flat lines and 
planes in a higher-dimensional mathematical representation of the input data (right). The actual 
input data (left) has only two dimensions, so, each axes corresponds to values of “features” (see 
main text) of the individual data points, one for horizontal and one for vertical. In its own natural two 
dimensions (left), the input data is inseparable by a line, but can be separated by a high-dimensional 
plane after transformation into the higher dimensional space (right) by SVM. The dashed decision 
boundary (left panel) is the class boundary which results from projecting the high-dimensional plane 
down onto the input space. (B) A graphical illustration of the computational algorithms underlying 
artificial neural networks. A simple artificial neuron (left) with two input feature values A and B. Each 
feature value is multiplied by a weight (w1, w2) and the result is added together, and forms the input 
to a mathematical function which is used to determine the predicted class output of the neuron (0 or 
1). A training algorithm applied to the training data determines the parameters of the algorithm 
which are the weight values. Simple artificial neurons such as these are connected together, input to 
output, into networks to make powerful classification algorithms, for example, a “two-layer feed-
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forward” network taking three feature inputs and producing two outputs (right). (C) Depicting 
decision trees and random forests (RF) for three-dimensional input feature data (top graph axes with 
f1 horizontal, f2 depth and f3 vertical, red/blue indicates training data class). A decision tree 
represents hierarchical splitting of the input data into rectangular regions which are “nested” inside 
each other, successively “zooming in” to a small region of the input space which contains only a few 
data points which are expected to belong to only one class. Each split occurs at specific values of the 
input features, giving rise to the decision boundaries (horizontal and vertical dashed black lines on 
small inset feature axes). To make a decision tree prediction, the feature values of an input data 
point determine which route down the tree to follow; obtaining a predicted class (red/blue 
diamonds) at the bottom of the tree. Random forests create many “randomized” decision trees by 
training each tree on a randomly chosen subset of both the training data and the feature axes. For a 
new input (white circles, inset feature axes), each decision tree is followed (thick black arrows) to 
obtain multiple class predictions, one from each tree (circled in orange). By majority vote over these 
predictions a final random forest class prediction is obtained (in this case red). 





Tasks Sensor(s) Machine Learning Algorithm Type of 
Algorithm 
Prediction Reported Results 
Hoff et al. 2001 [33] 23 PD specific 
activities of 
daily living 
accelerometers linear regression supervised dyskinesia correlation coefficient of 0.83, 0.87, 




2003 [34] 13 PD specific 
activities of 
daily living 
accelerometers neural network classifier supervised dyskinesia classification accuracy of 93.7%, 99.7%, 
and 97.0% in the arm, trunk, and leg, 
respectively 
Little et al. 2009 [35] 23 PD, 8 
controls 
voice voice recording support vector machine supervised Parkinson's 
disease 
overall classification accuracy of 91.4% 
Patel et al. 2009 [11] 12 PD specific 
motor tasks 
accelerometers support vector machine supervised tremor, 
bradykinesia, 
dyskinesia 
percent estimation error of 2.8% for 
tremor, 1.7% for bradykinesia, and 
1.2% for dyskinesia 
Cancela et 
al. 




k-nearest neighbor, decision tree, neural network, 
support vector machine 
unsupervised 
and supervised 
bradykinesia classification accuracy of 70-86%, 
depending on the algorithm 
Tsipouras 
et al. 








naïve Bayes, 5-nearest neighbor, decision trees, 
random forest 
supervised dyskinesia classification accuracy of 93.73% for 
levodopa-induced dyskinesia detection 
Zwartjes et 
al. 







decision tree supervised tremor, 
bradykinesia 
classification accuracy of 99.3% for 
activity classifier; correlation of 0.84 
with UPDRS tremor score 
Memedi et 
al. 




linear regression supervised total UPDRS correlation coefficient of 0.6 with total 
UPDRS 







neural network supervised tremor, dyskinesia sensitivity of 88.6-93.8%, specificity of 
91.9-94.6%, global error rate of 6.3-
8.4% for tremor; sensitivity of 90%, 
specificity of 91.3-95.5%, global error 
rate of 4.5-9.4% for dyskinesia 
Mazilu et 
al. 
2012 [28] 10 PD walking accelerometers, 
gyroscopes 
random trees, random forest, decision trees, naïve 
Bayes classifier, neural network classifier, k-
nearest neighbor 
supervised freezing of gait sensitivity of 99.69% and specificity of 
99.96% for detecting freezing of gait 
events 




accelerometers hidden Markov model classifier supervised tremor 
classification 











accelerometers support vector machine, sparse multinomial 
logistic regression 
supervised type of activity 
(e.g. sitting, 
standing, walking) 
cross-validation accuracy of 86% for 
SVM and 85.2% for SMLR 
Tripoliti et 
al. 







naïve Bayes classifier, random forest, decision 
trees, random trees 
supervised freezing of gait sensitivity of 81.94%, specificity of 
98.74%, classification accuracy of 
96.11% and AUC of 98.6% for freezing 
of gait events 
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random forest supervised UPDRS motor 
activities 
sensitivity of 96.2% and specificity of 
96.9% in PD diagnosis; average mean 
absolute error in modified motor 
UPDRS score of 1.26 points 
Wahid et 
al. 





cameras kernel Fisher discriminant, naïve Bayes classifier, 
k-nearest neighbor, support vector machine, 
random forest 
supervised gait disturbances, 
Parkinson's 
disease 
classification accuracy of 92.6% using 
random forests and multiple 
regression normalization 















decision tree classifier, naïve Bayes classifier, 
random forest, support vector machine, adaptive 








classification accuracy of 97% and AUC 
of 0.97 in classifying healthy aged 
controls from PD without MCI using 
adaptive boosting with decision tree 
and random resampling 








Q-back propagated time-delay neural network supervised gait disturbances, 
Parkinson's 
disease 
classification accuracy of 90.91-92.19% 
for PD, depending on the input dataset 
 
 
Table 1 citations: 




Table 2: Glossary of main machine learning terminology. 
Bayesian There are two different interpretations of probability in statistics. The frequentist 
interpretation defines probability as an intrinsic property of observations, for 
example, the observed prevalence probability of any one individual having 
Parkinson’s being estimated at around 150/100,000 from historical diagnosis 
data.  The Bayesian interpretation defines probability as a prior degree of belief 
(about e.g. a diagnosis) that is updated as more data arrives, for example, as the 
individuals symptoms are observed. 
Classification Assignment of input observation data to a category (e.g. diagnostic class: 
Parkinson's disease vs. healthy). 
Clustering Grouping observations in a dataset together under the same category/class 
where they are similar to each other according to their input data values. 
Cross-validation A method to estimate the prediction accuracy/performance of a machine 
learning model which would be expected to generalize beyond any particular 
dataset. It is a procedure whereby (1) the dataset is partitioned into a subset 
used to train the model and a subset to test model performance (hold-out 
testing), and (2) the procedure is repeated with different partitions of the 
dataset. 
Dimension The number of features in a dataset. For example, a dataset which includes 
height, weight, and blood pressure would have a dimension of three; a dataset 
with measurements from multiple sensors in a wearable device will usually have 
far higher dimension. 
Dimensionality 
reduction 
Decreasing the number of total features needed to capture all the useful 
information in the observations, e.g. by removing features that are highly 
correlated with other features (feature selection) or by deriving a smaller set of 
new features from combinations of the existing features (for example by using 
principal or independent components analysis). 
Feature Summarized input data that can be used to predict a corresponding output. For 
example, a summary of the patient’s accelerometer data from a wearable device 
or a clinical observation are both features that may be used to predict 
Parkinson's disease symptoms or diagnostic status. 
Hold-out testing A method to measure the accuracy/performance of a machine learning model in 
which a subset of the dataset is used to train the model and the remainder is 
used to test the accuracy of the model. 
Input/output A machine learning method is a mathematical algorithm or model that acts on 
input data to produce output data. For example, in classification, the input to the 
machine learning model is a high-dimensional data item or a smaller set of 
features, and the output is a predicted class label for a particular diagnosis. 
Label The “ground-truth” outputs (e.g. diagnostic classes/categories in disease 
classification or symptom severities in symptom severity regression) for a training 
subset. 
Learning/training The process of optimizing a machine learning algorithm, using training input data, 





A model is a set of mathematical equations which describes a (statistical/non-
statistical) relationship between variables, and implemented in software as a 
series of programming steps (algorithm). In the context of this article these 
models represent machine learning methods. 
Model 
complexity 
Usually characterized by either the number of input features required to make 
predictions, the number of assumptions, of the number of “degrees of freedom” 
implicit in a mathematical model. Overly complex models overfit the data by 
producing outputs that accurately predict the training data outputs but not the 
test data; overly simple models may not be sensitive enough to the input data to 
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make accurate predictions. 
Parametric/non-
parametric 
Types of machine learning models based upon assumptions about the input 
space. Linear regression is a parametric model, because it is specified by a finite 
set of parameters (the regression coefficients). Parametric models are typically 
straightforward to calculate and easily interpreted, but require assumptions 
about the input data which may be unrealistic. A non-parametric model (e.g. a 
kernel support vector machine) does not make simple assumptions such as 
linearity and so can discover arbitrary input-output relationships. While it can 
produce accurate predictions for complex input-output relationships, it is more 
difficult to calculate and often yields non-interpretable models. 
Prediction Typically, a prediction is an estimate of an output data quantity (such as a 
diagnostic category or a symptom severity measure) produced by a trained 
machine learning algorithm, using input data (such as sensor readings). 
Probabilistic 
graphical model 
A general mathematical framework for statistical modeling of complex 
phenomena by representing the relationships between all the variables (e.g. 
input features and outputs) in the problem as a graph of statistical dependencies 
between these variables. 
Regression Predicting the value of an output variable by the value of associated input 
variables and a known relationship between them. 
Regularization A method to control against overfitting by penalizing model complexity (for 
example additional input features in a regression or classification model), 
therefore allowing for a proper trade-off between training accuracy/performance 
and generalizability to other data. 
Replication 
testing 
Similar to hold-out testing but where the test subset is obtained from an entirely 





Machine learning algorithms that create a mathematical model to produce 
output data, trained on either labelled data (supervised), unlabelled data 
(unsupervised), or a mix of labelled and unlabelled data (semi-supervised). 
Test/train subset Machine learning algorithms create a predictive mathematical model by 
identifying patterns from observations in a training subset of a dataset. However, 
evaluation of the accuracy/performance of such a model is biased towards 
unrealistic accuracy if computed using the same training subset, and typically an 
independent test set is used to evaluate the performance of the model. 
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